Cart
sales@molnova.com
GGTI-2133
CAS No. 191102-79-1
GGTI-2133( —— )
Catalog No. M33985 CAS No. 191102-79-1
GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 375 | Get Quote |
|
| 5MG | 588 | Get Quote |
|
| 10MG | 905 | Get Quote |
|
| 25MG | 1371 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2484 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGGTI-2133
-
NoteResearch use only, not for human use.
-
Brief DescriptionGGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.
-
DescriptionGGTI-2133 is a direct and selective inhibitor of geran ylgeranyltransferase (GGTase). GGTI-2133 has the potential for eosinophilic airway inflammation such as asthma research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetTransferase
-
RecptorTransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number191102-79-1
-
Formula Weight456.54
-
Molecular FormulaC27H28N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N[C@@H](CC(C)C)C(O)=O)(=O)C1=C(C=2C3=C(C=CC2)C=CC=C3)C=C(NCC4=CN=CN4)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BQCA
BQCA a highly selective allosteric modulator of the M1 mAChR.
-
Norcantharidin
Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.
-
Miglustat hydrochlor...
Miglustat hydrochloride is an inhibitor of glucosylceramide synthase and can be used for studies about Type I Gaucher disease.
